Valora Therapeutics

Valora Therapeutics is a developer of a preclinical-stage biopharmaceutical company. The company focuses on developing a new class of biologics that enable the engineering of chimeric antibodies to unlock novel mechanisms of immune signaling and activity, helping clients develop transformative therapies for cancer and immune diseases.